BALTIMORE, Nov. 3, 2016 /PRNewswire/ -- Johns Hopkins University School of Medicine, one of the leading healthcare systems in the United States, and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), have collaborated to provide a free, community-focused CME workshop series to clinicians in the mid-atlantic and Appalachia regions of the country, HCV Education Summit: Building Integrated Care Teams to Combat the Growing Epidemic. " HCV infection has become a growing public health threat in the United States," said Mark Sulkowski, MD, Medical Director of the Viral Hepatitis Center at Johns Hopkins University School of Medicine in Baltimore, MD. " The recent development of highly effective antiviral regimens has led to a cure for most patients, making the eradication of HCV a feasible goal, but well-coordinated multidisciplinary care teams are equally necessary to achieve this objective." The collaboration between Johns Hopkins and Med-IQ on this initiative was formed to educate local clinicians on the barriers that influence the delivery of optimal, coordinated care to patients with hepatitis C virus (HCV) infection. Workshop participants explore strategies for identifying and managing HCV and learn best practices for forming local, cohesive, strategic care teams for patients with HCV and/or at high risk of HCV acquisition, such as those who are addicted to opioid medications. With 3 workshops scheduled in the Maryland and Pennsylvania areas, the goal is to educate as many clinicians as possible on this growing epidemic:
Baltimore, MD—November 19th
Waldorf, MD—December 12th
Pittsburgh, PA—December 17th
Interested clinicians can register for free by calling (toll-free) 866 858 7434, e-mailing email@example.com, or completing this brief online form. For more information on workshop locations and agenda, please visit www.Med-IQ.com/a972. These workshops are approved for AMA PRA Category 1 Credit™. This activity is supported by educational grants from AbbVie and Gilead Sciences, Inc.